HGH - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) $ in Millions |
Total |
ATM Equity Offering |
Preferred Stock |
Common Stock |
Common Stock
ATM Equity Offering
|
Additional Paid-In Capital |
Additional Paid-In Capital
ATM Equity Offering
|
Retained Earnings (Accumulated deficit) |
Accumulated Other Comprehensive Income (Loss) |
Treasury Stock |
| Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding (in shares) |
|
|
|
0
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
|
|
|
$ 0
|
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
|
|
|
0
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
307,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
|
$ 153
|
|
|
$ 5
|
|
$ 6,396
|
|
$ (2,502)
|
$ (316)
|
$ (3,430)
|
| Beginning balance, Treasury stock (in shares) at Dec. 31, 2024 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
(443)
|
|
|
|
|
|
|
(443)
|
|
|
| Other comprehensive income (loss) |
|
15
|
|
|
|
|
|
|
|
15
|
|
| Net settlement on vesting of restricted stock (in shares) |
|
|
|
|
1,000,000
|
|
|
|
|
|
|
| Net settlement on vesting of restricted stock |
|
(3)
|
|
|
|
|
(3)
|
|
|
|
|
| Stock-based compensation charges |
|
16
|
|
|
|
|
16
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2025 |
|
|
|
|
308,000,000
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2025 |
|
(262)
|
|
|
$ 5
|
|
6,409
|
|
(2,945)
|
(301)
|
$ (3,430)
|
| Ending balance, Treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Beginning balance at Dec. 31, 2024 |
|
|
|
0
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
|
|
$ 0
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2024 |
|
|
|
|
307,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2024 |
|
153
|
|
|
$ 5
|
|
6,396
|
|
(2,502)
|
(316)
|
$ (3,430)
|
| Beginning balance, Treasury stock (in shares) at Dec. 31, 2024 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
(737)
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
310,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
(504)
|
|
|
$ 5
|
|
6,421
|
|
(3,239)
|
(261)
|
$ (3,430)
|
| Ending balance, Treasury stock (in shares) at Jun. 30, 2025 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding (in shares) |
|
|
|
0
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
|
|
|
$ 0
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
|
|
$ 0
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2025 |
|
|
|
|
308,000,000
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2025 |
|
(262)
|
|
|
$ 5
|
|
6,409
|
|
(2,945)
|
(301)
|
$ (3,430)
|
| Beginning balance, Treasury stock (in shares) at Mar. 31, 2025 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
(294)
|
|
|
|
|
|
|
(294)
|
|
|
| Other comprehensive income (loss) |
|
40
|
|
|
|
|
|
|
|
40
|
|
| Net settlement on vesting of restricted stock (in shares) |
|
|
|
|
2,000,000
|
|
|
|
|
|
|
| Net settlement on vesting of restricted stock |
|
(4)
|
|
|
|
|
(4)
|
|
|
|
|
| Stock-based compensation charges |
|
16
|
|
|
|
|
16
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2025 |
|
|
|
|
310,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2025 |
|
$ (504)
|
|
|
$ 5
|
|
6,421
|
|
(3,239)
|
(261)
|
$ (3,430)
|
| Ending balance, Treasury stock (in shares) at Jun. 30, 2025 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding (in shares) |
|
|
|
0
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding (in shares) |
|
0
|
|
0
|
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2026 |
|
|
|
0
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
311,731,792
|
|
|
312,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
|
$ (459)
|
|
|
$ 5
|
|
6,447
|
|
(3,249)
|
(232)
|
$ (3,430)
|
| Beginning balance, Treasury stock (in shares) at Dec. 31, 2025 |
|
174,812,044
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ (333)
|
|
|
|
|
|
|
(333)
|
|
|
| Other comprehensive income (loss) |
|
(4)
|
|
|
|
|
|
|
|
(4)
|
|
| Net settlement on vesting of restricted stock (in shares) |
|
|
|
|
3,000,000
|
|
|
|
|
|
|
| Net settlement on vesting of restricted stock |
|
(7)
|
|
|
|
|
(7)
|
|
|
|
|
| Stock-based compensation charges |
|
17
|
|
|
|
|
17
|
|
|
|
|
| Ending balance (in shares) at Mar. 31, 2026 |
|
|
|
|
315,000,000
|
|
|
|
|
|
|
| Ending balance at Mar. 31, 2026 |
|
(786)
|
|
|
$ 5
|
|
6,457
|
|
(3,582)
|
(236)
|
$ (3,430)
|
| Ending balance, Treasury stock (in shares) at Mar. 31, 2026 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Beginning balance at Dec. 31, 2025 |
|
0
|
|
0
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Dec. 31, 2025 |
|
311,731,792
|
|
|
312,000,000
|
|
|
|
|
|
|
| Beginning balance at Dec. 31, 2025 |
|
$ (459)
|
|
|
$ 5
|
|
6,447
|
|
(3,249)
|
(232)
|
$ (3,430)
|
| Beginning balance, Treasury stock (in shares) at Dec. 31, 2025 |
|
174,812,044
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ (269)
|
|
|
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
355,918,045
|
|
|
356,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
$ (628)
|
|
|
$ 5
|
|
6,557
|
|
(3,518)
|
(242)
|
$ (3,430)
|
| Ending balance, Treasury stock (in shares) at Jun. 30, 2026 |
|
174,812,044
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding (in shares) |
|
|
|
0
|
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
|
|
|
$ 0
|
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
$ 0
|
|
$ 0
|
|
|
|
|
|
|
|
| Beginning balance (in shares) at Mar. 31, 2026 |
|
|
|
|
315,000,000
|
|
|
|
|
|
|
| Beginning balance at Mar. 31, 2026 |
|
(786)
|
|
|
$ 5
|
|
6,457
|
|
(3,582)
|
(236)
|
$ (3,430)
|
| Beginning balance, Treasury stock (in shares) at Mar. 31, 2026 |
|
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
|
|
|
|
|
|
| Net income (loss) |
|
64
|
|
|
|
|
|
|
64
|
|
|
| Other comprehensive income (loss) |
|
(6)
|
|
|
|
|
|
|
|
(6)
|
|
| Net settlement on vesting of restricted stock (in shares) |
|
|
|
|
3,000,000
|
|
|
|
|
|
|
| Net settlement on vesting of restricted stock |
|
(6)
|
|
|
|
|
(6)
|
|
|
|
|
| Stock-based compensation charges |
|
21
|
|
|
|
|
21
|
|
|
|
|
| Shares issued under the ATM Program (in shares) |
|
|
|
|
|
1,000,000
|
|
|
|
|
|
| Shares issued under the ATM Program |
|
|
$ 3
|
|
|
|
|
$ 3
|
|
|
|
| Share Lending Agreement (in shares) |
[1] |
$ 82
|
|
|
|
|
82
|
|
|
|
|
| Share Lending Agreement |
[1] |
|
|
|
37,000,000
|
|
|
|
|
|
|
| Ending balance (in shares) at Jun. 30, 2026 |
|
355,918,045
|
|
|
356,000,000
|
|
|
|
|
|
|
| Ending balance at Jun. 30, 2026 |
|
$ (628)
|
|
|
$ 5
|
|
$ 6,557
|
|
$ (3,518)
|
$ (242)
|
$ (3,430)
|
| Ending balance, Treasury stock (in shares) at Jun. 30, 2026 |
|
174,812,044
|
|
|
|
|
|
|
|
|
175,000,000
|
| Increase (Decrease) in Temporary Equity [Roll Forward] |
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, shares outstanding (in shares) |
|
0
|
|
0
|
|
|
|
|
|
|
|
|
|